Neutropenic Enterocolitis in a Breast Cancer Patient using Adjuvant Chemotherapy: Case Report
DOI:
https://doi.org/10.32635/2176-9745.RBC.2021v67n1.1188Keywords:
Enterocolitis, Neutropenic/drug therapy, Drug-Related Side Effects and Adverse Reactions, Breast Neoplasms, Male, Chemotherapy, Adjuvant, Patient Care TeamAbstract
Introduction: Neutropenic enterocolitis (NE) consists of ulceration or necrosis of the mucosa of the cecum, terminal ileum, and ascending colon, being a clinical condition caused by an adverse drug event, mainly in chemotherapy regimens. As it is a high mortality rate condition, this report aims to contribute significantly to discussions involving NE and the participation of the multidisciplinary team in the clinical outcome. Case report: This is a 75-year-old male patient diagnosed with Breast Cancer, who developed EN after treatment with adjuvant chemotherapy. The presence of comorbidities and age were the main complicating factors in typhlitis. As it is an important toxicity and can lead to a worsening of the clinical condition of cancer patients, addressing this issue is essential for a faster diagnosis with the possibility of preventive measures. Conclusion: Therefore, in view of the notorious increase of cases of NE, the perspective of the qualification of the health team is pointed out, for the inclusion of even more specialized professionals capable of contributing and identifying the signs and symptoms related to hematological toxicities, result of chemotherapy treatments.